BIODESIX, INC. Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
BIODESIX, INC. (BDSX) had Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net of $3.18 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes
us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet · last filed 2026-08-05
- 2026-06-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $3.18M.
- 2026-03-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $3.51M.
- 2025-12-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $2.56M.
- 2025-09-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $2.89M.
| Period end | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net as first filed |
|---|---|---|
| 2026-06-30 | $3.18M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $3.51M 10-Q · filed 2026-05-04 | |
| 2025-12-31 | $2.56M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $2.89M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $3.22M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $3.31M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $3.60M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $3.90M 10-Q · filed 2024-11-01 | |
| 2024-06-30 | $4.21M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $4.51M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $4.80M 10-K · filed 2025-03-03 | |
| 2023-09-30 | $5.09M 10-Q · filed 2023-11-07 | |
| 2023-06-30 | $5.39M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $4.98M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $5.07M 10-K · filed 2024-03-01 | |
| 2022-09-30 | $2.33M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $2.95M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $59.00K 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $63.00K 10-K · filed 2023-03-06 | |
| 2021-09-30 | $85.00K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $109.00K 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $90.00K 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $313.00K 10-K · filed 2022-03-14 | |
| 2020-09-30 | $349.00K 10-Q · filed 2020-12-10 | |
| 2019-12-31 | $1.46M 10-K · filed 2021-03-16 | $458.00K 10-Q · filed 2020-12-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |